EHRA Premium Access

Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database

Topic: Epidemiology, Prognosis, Outcome

Congress Presentation

About the speaker

Doctor Ameenathul Mazaya Fawzy

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

4 more presentations in this session

The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study

Speaker: Doctor V. Artola (Groningen, NL)

Thumbnail

Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study.

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Thumbnail

Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project

Speaker: Doctor A. Fawzy (Liverpool, GB)

Thumbnail

Access the full session

New on atrial fibrillation

Speakers: Doctor A. Fawzy, Doctor V. Artola, Professor L. Fauchier, Doctor A. Fawzy, Doctor A. Fawzy
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb